Global stocks fall on worries over EU stimulus details, coronavirus drug
Send a link to a friend
[April 24, 2020]
By Tom Arnold
LONDON (Reuters) - Global shares fell on
Friday, hit by delays to an agreement on divisive details of the
European Union's stimulus package and doubts about progress in the
development of drugs to treat COVID-19.
MSCI's All Country World Index, which tracks stocks across 49 countries,
was down 0.3% and heading for its worst week in three, while MSCI's
broadest index of Asia-Pacific shares outside Japan fell 0.9%.
European stocks were 0.3% lower, with London's FTSE 100 shedding 0.6% as
data showed UK retail sales crashed in March.
"It's a negative session," said François Savary, chief investment
officer at Swiss wealth manager Prime Partners. "The market for the last
week has been under consolidation after a strong rally. A lot of good
news has already been priced in and news that the number of deaths had
increased in the U.S. was also a warning sign for investors."
Avoiding another all-night bust-up, EU leaders agreed on Thursday to
build a trillion euro emergency fund to help recover from the
coronavirus pandemic, while leaving divisive details until the summer.
French President Emmanuel Macron said differences continued between EU
governments over whether the fund should be transferring grant money, or
simply making loans.
"The risk exists that a concrete decision on the creation of the
recovery fund may not occur before September, thereby not being
operational before early 2021," Goldman Sachs European economist Alain
Durre wrote in a note.
The banking index led the declines in European stocks after S&P cut
Commerzbank's credit rating by a notch and lowered its outlook for
Deutsche Bank to negative from stable.
U.S. stock futures swung into positive territory, rising 0.6%. The S&P
500 and the Nasdaq turned negative at the close on Thursday in the wake
of a report that Gilead Sciences Inc's antiviral drug remdesivir had
failed to help severely ill COVID-19 patients in its first clinical
trial.
Gilead said the findings were inconclusive because the study conducted
in China was terminated early.
The markets' sensitivity to news related to the medical treatment of
COVID-19 reflected investors' desperation for a sign of when the global
economy might start returning to normal, said Tim Ghriskey, chief
investment strategist at New York-based wealth management firm Inverness
Counsel.
"Any piece of bad news is likely to rattle the market," Ghriskey said.
"Investors are keen for a semblance of hope that they can soon crawl out
of their homes and get on with some form of normal life, even if with
trepidation and fear."
[to top of second column]
|
The German share price index DAX graph is pictured at the stock
exchange in Frankfurt, Germany, April 23, 2020. REUTERS/Staff/File
Photo
U.S. coronavirus deaths exceeded 49,000 on Thursday, with the number
of lives lost in April rising by an average of 2,000 a day,
according to a Reuters tally.
Business activity in the world's largest economy plumbed record lows
in April, mirroring dire figures from Europe and Asia as strict
stay-at-home orders crushed production, supply chains and consumer
spending, a survey showed.
The U.S. House of Representatives on Thursday passed a $484 billion
bill to expand federal loans to small businesses and hospitals
overwhelmed by patients.
President Donald Trump, who has indicated he will sign the bill,
said late Thursday he may need to extend social distancing
guidelines to early summer.
Oil prices broadly retained their recovery from a price collapse
this week that pushed U.S. crude futures into negative territory for
the first time ever, helped by producers such as Kuwait saying they
would move to cut output.
Brent crude was up 18 cents, or 0.9%, at $21.51, after jumping 5% on
Thursday. U.S. oil was steady at $16.50 a barrel, having surged 20%
in the previous session.
But prices were headed for their third weekly loss and the outlook
remains dim because global energy demand has evaporated due to
business closures and travel curbs aimed at slowing the pandemic. In
addition, some countries are running out of space to store the crude
oil that they are not using.
EU leaders' agreement on the emergency fund helped lift Italian
government bond yields. Short-dated Italian bond yields jumped 12
basis points. Italy's 10-year bond yield was up 7 bps at 2.08% and
the closely-watched Italian/German 10-year bond yield gap was 14 bps
wider from late Thursday levels at around 252 bps, erasing
Thursday's narrowing.
The U.S. dollar gained as the euro fell 0.2% against the greenback
to $1.07980 and 0.2% versus the yen at 116.17 yen.
(Additional reporting by Stanley White in Tokyo; editing by Nick
Macfie and Mark Potter)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |